Cencora | COR - Selling And Administration Expenses

Stock Price
257.71
Daily Change
-3.40 -1.30%
Monthly
-20.06%
Yearly
-11.20%
Q2 Forecast
255.68

Cencora reported $1.8B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Ambu A/S DKK 684M 5M Mar/2026
Apollo Hospitals Enterprise Ltd INR 7.25B 382M Mar/2025
Avanos Medical USD 77.7M 1.1M Mar/2026
Brookdale Senior Living USD 4.22B 4.19B Mar/2026
Cencora USD 1.8B 46.42M Dec/2025
Coloplast 2.64B 52M Dec/2025
Convatec Group USD 420.3M 210.35M Dec/2024
Diasorin EUR 56M 49.25M Mar/2026
Encompass Health USD 58.2M 10.2M Mar/2026
Enovis USD 282.81M 12.37M Mar/2026
GE HealthCare Technologies USD 1.11B 145M Dec/2025
Gulf Medical Proj AED 915K 52K Dec/2025
Hoya 15.96B 471M Mar/2026
Med Life RON 23.07M 3.23M Sep/2025
Oriola-kd EUR 13M 3.1M Sep/2025
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Rede D'or Sao Luiz BRL 145.65M 76.19M Mar/2026
Siemens Healthineers EUR 963M 38M Mar/2026
Solventum Corp USD 783M 24M Mar/2026
Sonova Holding CHF 880.2M 300K Jun/2025
Veradigm USD 27.28M 5.24M Dec/2022
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026